U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H22N4O2S
Molecular Weight 370.469
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TELENZEPINE

SMILES

CN1CCN(CC(=O)N2C3=C(C)SC=C3C(=O)NC4=CC=CC=C24)CC1

InChI

InChIKey=VSWPGAIWKHPTKX-UHFFFAOYSA-N
InChI=1S/C19H22N4O2S/c1-13-18-14(12-26-13)19(25)20-15-5-3-4-6-16(15)23(18)17(24)11-22-9-7-21(2)8-10-22/h3-6,12H,7-11H2,1-2H3,(H,20,25)

HIDE SMILES / InChI

Molecular Formula C19H22N4O2S
Molecular Weight 370.469
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Telenzepine is a selective muscarinic M1 receptor antagonist that was studied for selective inhibition of gastric acid secretion. Telenzepine was used in clinical trials in patients with acute duodenal ulcer, where was found that once daily administration of 3 mg in the evening must be regarded as the optimal dosage regimen of telenzepine. However, the preregistration for peptic ulcer in Germany was discontinued. In addition, the drug was studied in patients with nocturnal asthma. It was shown that telenzepine via the oral route at a dose of up to 5 mg was not effective in preventing nocturnal asthma.

Approval Year

Targets

Targets

PubMed

PubMed

TitleDatePubMed
The existence of stable enantiomers of telenzepine and their stereoselective interaction with muscarinic receptor subtypes.
1989 Apr
Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes.
1989 Nov 28
Assessment of the muscarinic receptor subtypes involved in pilocarpine-induced seizures in mice.
1994 Feb 28
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
1999 Jan 1
Distinct muscarinic receptors enhance spontaneous GABA release and inhibit electrically evoked GABAergic synaptic transmission in the chick lateral spiriform nucleus.
2001
Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
2002 Dec 20
Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands.
2003 Aug
PMA decreases the proliferation of retinal cells in vitro: the involvement of acetylcholine and BDNF.
2003 Jan
Cholinergic modulation of memory in the basolateral amygdala involves activation of both m1 and m2 receptors.
2003 May
Muscarinic acetylcholine receptors potentiate the GABAergic transmission in the developing rat inferior colliculus.
2003 Sep
Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism.
2008 Mar 17

Sample Use Guides

120 patients with endoscopically proven, florid duodenal ulcer were treated with either 1.5 mg, 3 mg or 5 mg telenzepine once daily at bedtime (40 patients per dose group).
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:32:36 GMT 2023
Edited
by admin
on Fri Dec 15 16:32:36 GMT 2023
Record UNII
0990EG3K10
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TELENZEPINE
INN   MART.   MI   WHO-DD  
INN  
Official Name English
NSC-758679
Code English
10H-THIENO(3,4-B)(1,5)BENZODIAZEPIN-10-ONE, 4,9-DIHYDRO-3-METHYL-4-(2-(4-METHYL-1-PIPERAZINYL)ACETYL)-
Common Name English
TELENZEPINE [MART.]
Common Name English
telenzepine [INN]
Common Name English
TELENZEPINE [MI]
Common Name English
4,9-DIHYDRO-3-METHYL-4-(2-(4-METHYL-1-PIPERAZINYL)ACETYL)-10H-THIENO(3,4-B)(1,5)BENZODIAZEPIN-10-ONE
Systematic Name English
Telenzepine [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29704
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
Code System Code Type Description
EVMPD
SUB10871MIG
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
SMS_ID
100000082461
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
PUBCHEM
5387
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
NSC
758679
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
INN
5379
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
MESH
C046338
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
NCI_THESAURUS
C75285
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
WIKIPEDIA
Telenzepine
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
MERCK INDEX
m952
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID5045209
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
FDA UNII
0990EG3K10
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
ChEMBL
CHEMBL253978
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
CAS
80880-90-6
Created by admin on Fri Dec 15 16:32:36 GMT 2023 , Edited by admin on Fri Dec 15 16:32:36 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY